What does this research mean for the field?

Distinct etiologies of chronic liver disease, such as hepatitis B, alcohol-associated liver disease, and drug-induced liver injury, are associated with specific, differentiating gut microbiome and metabolome profiles. Novelty: ClaimNovelty.INCREMENTAL. Consensus alignment: ConsensusAlignment.NEUTRAL.

What question did this study set out to answer?

Investigate potential gut microbiome and metabolome differences across diverse etiologies of chronic liver disease along the gut-liver axis.

September 14, 2026Gut PathogensOpen Access

Gut microbiome and metabolome profiles in diverse etiologies of chronic liver disease

View Full Paper

Ask AI

Bookmark

Authors

HLHuimin Liu YZYan Zhu WCWenting Chen

Discussion

Member takes

Implication

Exploratory multi-omics study reveals distinct gut microbiome and metabolome profiles across chronic liver disease etiologies, indicating candidate markers for patient stratification.

Key Points

Investigate potential gut microbiome and metabolome differences across diverse etiologies of chronic liver disease along the gut-liver axis.
Recruited 80 patients with chronic liver disease (53 HBV, 7 ALD, 6 DILI, and 14 other causes) alongside 40 demographically matched healthy controls.
Prospectively collected fecal samples for metagenomic sequencing and non-targeted metabolomic profiling, as well as small intestinal mucosal biopsies for metagenomic sequencing in a 25-patient subset.
The alcohol-associated liver disease group showed compositional differences in gut microbiota and predicted functional pathways relative to other etiologies.
Untargeted metabolomic analysis identified etiology-associated metabolic signatures, with several metabolite panels demonstrating preliminary discriminatory capacity between disease groups.
Integrated multi-omics analyses revealed correlations between specific gut bacterial taxa and host-microbe metabolic pathways functioning along the gut-liver axis.

Cite This Study

Liu et al. (2026) studied this question.

synapsesocial.com/papers/6aa7b3ee0926e14a848b34e5 https://doi.org/10.1186/s13099-026-00877-7

View Full Paper

Ask AI

Bookmark

September 14, 2026Gut PathogensOpen Access

Gut microbiome and metabolome profiles in diverse etiologies of chronic liver disease

View Full Paper

Ask AI

Bookmark

Authors

HLHuimin Liu YZYan Zhu WCWenting Chen

Discussion

Member takes

Implication

Exploratory multi-omics study reveals distinct gut microbiome and metabolome profiles across chronic liver disease etiologies, indicating candidate markers for patient stratification.

Key Points

Investigate potential gut microbiome and metabolome differences across diverse etiologies of chronic liver disease along the gut-liver axis.
Recruited 80 patients with chronic liver disease (53 HBV, 7 ALD, 6 DILI, and 14 other causes) alongside 40 demographically matched healthy controls.
Prospectively collected fecal samples for metagenomic sequencing and non-targeted metabolomic profiling, as well as small intestinal mucosal biopsies for metagenomic sequencing in a 25-patient subset.
The alcohol-associated liver disease group showed compositional differences in gut microbiota and predicted functional pathways relative to other etiologies.
Untargeted metabolomic analysis identified etiology-associated metabolic signatures, with several metabolite panels demonstrating preliminary discriminatory capacity between disease groups.
Integrated multi-omics analyses revealed correlations between specific gut bacterial taxa and host-microbe metabolic pathways functioning along the gut-liver axis.

Cite This Study

Liu et al. (2026) studied this question.

synapsesocial.com/papers/6aa7b3ee0926e14a848b34e5 https://doi.org/10.1186/s13099-026-00877-7

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

View Full Paper

Ask AI

Bookmark